ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00317629
Recruitment Status : Terminated (An interim analysis showed that nitric oxide patches are not enough effective)
First Posted : April 25, 2006
Last Update Posted : November 24, 2010
Sponsor:
Collaborators:
Universidad de Antioquia
The University of Akron
Universidad de Santander
Secretaria de Salud de Santander
Secretaria de Salud de Tolima
Information provided by:
Fundación Cardiovascular de Colombia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2009
  Actual Study Completion Date : March 2009